May 25, 2022
In May, WIPO released version 2.0 of the WIPO Sequence Suite software, which helps applicants prepare biological sequence listings for patent applications.
WIPO Sequence desktop tool allows patent applicants to format sequence listings – including DNA, RNA and amino acids – compliant with WIPO Standard ST.26. Biotechnology applications filed after June must observe the global transition to ST.26 on July 1, 2022.
WIPO Sequence is the first software distribution produced by WIPO for use by patent applicants worldwide, standardizing a drafting process that varied from office to office. All patent offices have committed to support the software so that applicants across the world have access to the same free tool for their sequence listings. Packages for Windows, Mac OS, and Linux are available on the WIPO Sequence webpage.
With the latest release, WIPO has also launched two new resources to support patent applicants with generating WIPO ST.26-compliant sequence listings: a knowledge base and an email notification list. Training webinars on WIPO Sequence have been provided in all 10 PCT languages, with recordings available on the WIPO website. The software user manual has also been updated.
The knowledge base, which will launch in June, contains answers to frequently asked questions posed to WIPO and patent offices and tips on how to solve common issues with WIPO Sequence and ST.26. The content is provided initially in English, with machine translations to be made available over time in all other languages, including Arabic, Chinese, French, Russian, and Spanish.
An important part of the knowledge base is points of contact for IP offices, where applicants can find ways to contact offices where they file. This helps applicants talk directly to the most knowledgeable source for questions about preparing sequence listings for their application.
The e-mail notification list provides updates on new releases and important messages about WIPO Sequence. Users are encouraged to sign up for the list by going to the registration page.